Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TNXP

+ Watchlist+ Portfolio

Tonix Pharmaceuticals Holding Corp.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.82
52-Week Range
$2.53 – $20.56
Market Cap
$49.55M
P/E (TTM)
—
EPS (TTM)
-12.39
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.24
PEG Ratio
—
Return on Equity
-84.06%
Return on Assets
-47.44%
Gross Margin
89.33%
Operating Margin
-436.25%
Profit Margin
0.00%
Current Ratio
4.57
Debt/Equity
0.01
Total Debt
$1.25M
Free Cash Flow
$-102.01M
Revenue Growth
423.80%
Earnings Growth
—
Enterprise Value
$-106.74M

Market Snapshot

About

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company developing therapeutics to treat pain, neurologic, psychiatric, and immunologic conditions. The company has a diverse pipeline including product candidates for PTSD, fibromyalgia, Long COVID, and infectious diseases. Tonix also develops vaccines and immunotherapies using proprietary technology platforms.